| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5656405 | HPB | 2017 | 11 Pages |
Abstract
RIPC is acceptable and safe in liver transplant recipients. This study has not demonstrated evidence of a reduction in short-term measures of IR injury. Longer follow up will be required and consideration of an altered protocol.
Related Topics
Health Sciences
Medicine and Dentistry
Endocrinology, Diabetes and Metabolism
Authors
Francis P. Robertson, Rup Goswami, Graham P. Wright, Charles Imber, Dinesh Sharma, Massimo Malago, Barry J. Fuller, Brian R. Davidson,